Seán Canney TD, Minister of State for International and Road Transport, Logistics, Rail and Ports and Leader in Cabinet of the Independent Ministers, has welcomed significant investment for Galway under the Government’s latest round of the Disruptive Technologies Innovation Fund (DTIF).
Atlantic Technological University (ATU) will receive €6.3m as part of the PIONEER project, in partnership with AuriGen Medical Ltd, Integer Holdings Corporation – Brivant Limited, Aran Biomedical. The project is advancing a next-generation project to improve outcomes for high-risk atrial fibrillation patients.
“As a former lecturer in GMIT, now ATU, I am especially proud to see the university playing a central role in pioneering research of this scale and ambition,” Minister Canney said.
“This investment will not only deliver new solutions in healthcare but will also create high-quality research and innovation opportunities for students and staff in Galway.”
Other Galway projects also secured substantial awards today:
- ECORE (€6.0m): Galway-headquartered LaNua Medical and Integer Holdings, working with UCD, will develop a targeted embolisation device for vascular disorders and cancers.
- FutureLives (€2.9m): University of Galway along with GlasPort Bio and Agri-IOT Ltd will develop climate-smart agri-technologies to reduce emissions and improve nutrient efficiency.
- cueStim-Stroke (€2.1m): Galway-based Fortis Medical Devices Teoranta, partnering with Smart Electronics Ltd and RCSI, will deliver the world’s first bilateral sensory electrical stimulation device for stroke rehabilitation.
Minister Canney continued: “Galway has rightly earned its reputation as the beating heart of Ireland’s med-tech and life sciences sector, with ATU, the University of Galway and leading local enterprises all driving innovation. The €17 million in funding secured today is about more than research—it is about creating jobs, supporting our universities, driving innovation in SMEs, and ensuring the West remains at the forefront of global healthcare and sustainability solutions.”
ENDS
Note to Editors
The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under the National Development Plan (NDP) in 2018. It supports collaboration between Ireland’s research base and industry to drive the commercialisation of cutting-edge technologies. The Department of Enterprise, Tourism and Employment manages the DTIF with support from Enterprise Ireland.
Galway Projects Funded under DTIF Call 7
- PIONEER – €6.3m
Consortium: AuriGen Medical Ltd, Integer Holdings Corporation – Brivant Limited, Aran Biomedical, and Atlantic Technological University (ATU). (all Galway)
Focus: Development of a next-generation, repositionable left atrial appendage occluder for high-risk atrial fibrillation patients. - ECORE – €6.0m
Consortium: LaNua Medical (Galway), Integer Holdings (Galway), and University College Dublin (UCD).
Focus: Development and validation of an embolisation device to deliver targeted therapies for vascular disorders and cancers. - FutureLives – €2.9m
Consortium: University of Galway, GlasPort Bio Ltd (Galway), GlasPort Rumen Tech Ltd, and Agri-IOT Ltd.
Focus: Enhancing nutrient efficiency and reducing greenhouse gas emissions to support a more climate-resilient agricultural sector. - cueStim-Stroke – €2.1m
Consortium: Fortis Medical Devices Teoranta (Galway), Smart Electronics Ltd, and Royal College of Surgeons in Ireland (RCSI).
Focus: Development of the world’s first bilateral sensory electrical stimulation technology for stroke-related gait rehabilitation.
